Literature DB >> 11038437

Japanese family with an autosomal dominant chromosome instability syndrome: a new neurodegenerative disease?

S Ishikawa1, M Ishikawa, T Tokuda, K Yoshida, K Wakui, S Matsuura, S Ohara, Y Sekijima, E Hidaka, Y Fukushima, H Shigeta, K Komatsu, S Ikeda.   

Abstract

We report on a Japanese family having an autosomal dominant neurodegenerative disease with chromosomal instability and radiosensitivity. Clinical manifestations of affected members included short stature, osteoporosis, severe dental caries, and various neurological abnormalities, such as mental retardation, depression, dysarthria, hyperreflexia, and ataxic gait. MRI demonstrated a markedly atrophic spinal cord and degeneration of the white matter. Cytogenetic examination showed spontaneous chromosome rearrangements at 14q11.2 and hypersensitivity to radiation and bleomycin. The degree of these cytogenetic abnormalities was significantly higher in the patients than in normal controls but lower than in patients with ataxia telangiectasia or Nijmegen breakage syndrome. Moreover, genetic anticipation was observed in this family: the age of disease onset became earlier, MRI abnormalities more extensive, and the chromosome hypersensitivity to radiation increased in successive generations. We speculate that a basic defect in this family is a mutation in the gene that is responsible for DNA double-strand breakage repair. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11038437     DOI: 10.1002/1096-8628(20001002)94:4<265::aid-ajmg1>3.0.co;2-#

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  1 in total

1.  2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family.

Authors:  Claudia Béu Volpato; Alessandro De Grandi; Ebba Buffone; Maurizio Facheris; Uwe Gebert; Günther Schifferle; Rudolf Schönhuber; Andrew Hicks; Peter P Pramstaller
Journal:  J Mol Neurosci       Date:  2009-11       Impact factor: 3.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.